An Insight into Medicinal Chemistry of Anticancer Drugs
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 December 2025) | Viewed by 27811
Special Issue Editors
Interests: drug repurposing in cancer research; pharmacogenetics; medicinal chemistry
Interests: natural products; therapeutic properties; skin cancer; neurosciences
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is one of the most common causes of death worldwide, making it a serious threat to the well-being and lives of people. Likewise, current treatments have diverse limitations, including unwanted side effects and resistance development. Therefore, the multifactorial and complex nature of cancer represents a global challenge to human health, requiring a comprehensive understanding of the underlying mechanisms and investigations of innovative therapeutic strategies.
This Special Issue welcomes original research and reviews articles covering distinct aspects of cancer research from different perspectives, including but not limited to the mechanisms of action of antitumor drugs, novel treatments, the relationship between chemical structure and antitumor agents' biological activity, cancer immunotherapy, polypharmacology, drug resistance, and multitargeted therapy. We are confident this Special Issue will be a valuable resource for students, researchers, and practitioners in medicine, pharmacology, and related health sciences.
Prof. Dr. Gabriela Figueroa-González
Dr. Hernán Cortés
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural products
- anticancer
- synthesis
- drug resistance
- multitargeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
